- Report
- February 2026
- 35 Pages
Germany
From €4592EUR$4,995USD£3,913GBP
- Report
- February 2026
- 34 Pages
Canada
From €4592EUR$4,995USD£3,913GBP
- Report
- January 2026
- 78 Pages
From €3171EUR$3,450USD£2,703GBP
- Report
- December 2025
- 33 Pages
Australia
From €4592EUR$4,995USD£3,913GBP
- Report
- July 2025
- 132 Pages
Global
From €4458EUR$4,850USD£3,800GBP
- Report
- June 2025
- 89 Pages
North America
From €3171EUR$3,450USD£2,703GBP
- Report
- June 2025
- 81 Pages
Middle East, Africa
From €3171EUR$3,450USD£2,703GBP
- Report
- June 2025
- 97 Pages
Asia Pacific
From €3631EUR$3,950USD£3,095GBP
- Report
- June 2025
- 100 Pages
Europe
From €3631EUR$3,950USD£3,095GBP
- Report
- June 2025
- 109 Pages
Global
From €3171EUR$3,450USD£2,703GBP
- Report
- June 2025
- 81 Pages
From €3171EUR$3,450USD£2,703GBP
- Report
- June 2025
- 198 Pages
Global
From €4550EUR$4,950USD£3,878GBP
- Report
- June 2025
- 90 Pages
United States
From €1838EUR$1,999USD£1,566GBP
- Report
- May 2025
- 600 Pages
Global
From €1287EUR$1,400USD£1,097GBP
- Report
- May 2025
- 600 Pages
Global
From €1287EUR$1,400USD£1,097GBP
- Report
- April 2025
- 225 Pages
Global
From €4137EUR$4,500USD£3,526GBP
- Report
- April 2025
- 44 Pages
United States
- Report
- March 2025
- 145 Pages
Global
From €4458EUR$4,850USD£3,800GBP
- Report
- March 2025
- 260 Pages
Middle East
From €2666EUR$2,900USD£2,272GBP
- Report
- March 2025
- 260 Pages
Africa
From €2666EUR$2,900USD£2,272GBP

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump.
The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more